A Message from the President of Novo Nordisk Inc.

You may have seen recent news reports about a possible safety concern for people with diabetes. According to recent scientific publications, more research is needed to see if there is a possibility that having diabetes, or taking certain drugs to treat diabetes, may increase the chances of getting cancer. Medical experts continue to study this issue.

In the meantime, it is important to for you to continue to treat your diabetes according to your doctor’s instructions, because the complications from untreated diabetes can be serious.

We value your trust and confidence in our products and company. As a world leader in diabetes care, Novo Nordisk has been making drugs for diabetes treatment for more than 87 years.

All of our products have been extensively studied in clinical trials and we constantly monitor our products to see if they cause negative side effects once they are used by the general public.

I, too, have diabetes and I take Levemir everyday and I felt that this information was important to share with you.

If you are confused by any information you are hearing, please talk to your doctor. Please do not stop taking your medication, or make changes in your medications, without talking to your doctor first.

If you have any questions about Novo Nordisk products, call your doctor or our Customer Care Center at 1-800-727-6500.

Thank you for your continued trust in Novo Nordisk,

Jerzy Gruhn
President
Novo Nordisk Inc.

The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment. Talk to your doctor about the importance of diet and exercise in your treatment plan.

Novo Nordisk provides product assistance for those who qualify. Please call 866-310-7549 to learn more about Novo Nordisk assistance programs (as appropriate).

You are encouraged to report negative side effects of prescription drugs to the FDA.  Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Levemir® and NovoLog® are registered trademarks of Novo Nordisk A/S.